119 related articles for article (PubMed ID: 33984298)
1. Ouabain worsens diastolic sarcomere length in myocytes from a cardiomyopathy mouse model.
Düsener S; Flenner F; Maack C; Kohlhaas M; Bay J; Carrier L; Friedrich FW
Eur J Pharmacol; 2021 Aug; 904():174170. PubMed ID: 33984298
[TBL] [Abstract][Full Text] [Related]
2. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
[TBL] [Abstract][Full Text] [Related]
3. Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.
Fraysse B; Weinberger F; Bardswell SC; Cuello F; Vignier N; Geertz B; Starbatty J; Krämer E; Coirault C; Eschenhagen T; Kentish JC; Avkiran M; Carrier L
J Mol Cell Cardiol; 2012 Jun; 52(6):1299-307. PubMed ID: 22465693
[TBL] [Abstract][Full Text] [Related]
4. Translational investigation of electrophysiology in hypertrophic cardiomyopathy.
Flenner F; Jungen C; Küpker N; Ibel A; Kruse M; Koivumäki JT; Rinas A; Zech ATL; Rhoden A; Wijnker PJM; Lemoine MD; Steenpass A; Girdauskas E; Eschenhagen T; Meyer C; van der Velden J; Patten-Hamel M; Christ T; Carrier L
J Mol Cell Cardiol; 2021 Aug; 157():77-89. PubMed ID: 33957110
[TBL] [Abstract][Full Text] [Related]
5. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T
J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226
[TBL] [Abstract][Full Text] [Related]
6. Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy.
Flenner F; Friedrich FW; Ungeheuer N; Christ T; Geertz B; Reischmann S; Wagner S; Stathopoulou K; Söhren KD; Weinberger F; Schwedhelm E; Cuello F; Maier LS; Eschenhagen T; Carrier L
Cardiovasc Res; 2016 Jan; 109(1):90-102. PubMed ID: 26531128
[TBL] [Abstract][Full Text] [Related]
7. Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.
Najafi A; Sequeira V; Helmes M; Bollen IA; Goebel M; Regan JA; Carrier L; Kuster DW; Van Der Velden J
Cardiovasc Res; 2016 May; 110(2):200-14. PubMed ID: 26825555
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-Gallate Accelerates Relaxation and Ca
Friedrich FW; Flenner F; Nasib M; Eschenhagen T; Carrier L
Front Physiol; 2016; 7():607. PubMed ID: 27994558
[No Abstract] [Full Text] [Related]
9. Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy.
Flagg TP; Cazorla O; Remedi MS; Haim TE; Tones MA; Bahinski A; Numann RE; Kovacs A; Schaffer JE; Nichols CG; Nerbonne JM
Circ Res; 2009 Jan; 104(1):95-103. PubMed ID: 19023131
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene.
Martins AS; Parvatiyar MS; Feng HZ; Bos JM; Gonzalez-Martinez D; Vukmirovic M; Turna RS; Sanchez-Gonzalez MA; Badger CD; Zorio DAR; Singh RK; Wang Y; Jin JP; Ackerman MJ; Pinto JR
Circ Cardiovasc Genet; 2015 Oct; 8(5):653-664. PubMed ID: 26304555
[TBL] [Abstract][Full Text] [Related]
11. Na(+)/K)+)-ATPase α2-isoform preferentially modulates Ca2(+) transients and sarcoplasmic reticulum Ca2(+) release in cardiac myocytes.
Despa S; Lingrel JB; Bers DM
Cardiovasc Res; 2012 Sep; 95(4):480-6. PubMed ID: 22739122
[TBL] [Abstract][Full Text] [Related]
12. Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function.
van Dijk SJ; Paalberends ER; Najafi A; Michels M; Sadayappan S; Carrier L; Boontje NM; Kuster DW; van Slegtenhorst M; Dooijes D; dos Remedios C; ten Cate FJ; Stienen GJ; van der Velden J
Circ Heart Fail; 2012 Jan; 5(1):36-46. PubMed ID: 22178992
[TBL] [Abstract][Full Text] [Related]
13. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
[TBL] [Abstract][Full Text] [Related]
14. Sarcomere neutralization in inherited cardiomyopathy: small-molecule proof-of-concept to correct hyper-Ca2+-sensitive myofilaments.
Thompson BR; Martindale J; Metzger JM
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H36-43. PubMed ID: 27199134
[TBL] [Abstract][Full Text] [Related]
15. The α2-isoform of the Na
Cellini A; Höfler D; Arias-Loza PA; Bandleon S; Langsenlehner T; Kohlhaas M; Maack C; Bauer WR; Eder-Negrin P
Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H650-H662. PubMed ID: 34448639
[TBL] [Abstract][Full Text] [Related]
16. Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca
Sparrow AJ; Watkins H; Daniels MJ; Redwood C; Robinson P
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H715-H722. PubMed ID: 32083971
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.
Coppini R; Mazzoni L; Ferrantini C; Gentile F; Pioner JM; Laurino A; Santini L; Bargelli V; Rotellini M; Bartolucci G; Crocini C; Sacconi L; Tesi C; Belardinelli L; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Poggesi C
Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28255011
[TBL] [Abstract][Full Text] [Related]
18. Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.
Dweck D; Sanchez-Gonzalez MA; Chang AN; Dulce RA; Badger CD; Koutnik AP; Ruiz EL; Griffin B; Liang J; Kabbaj M; Fincham FD; Hare JM; Overton JM; Pinto JR
J Biol Chem; 2014 Aug; 289(33):23097-23111. PubMed ID: 24973218
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model.
Stücker S; Kresin N; Carrier L; Friedrich FW
Front Physiol; 2017; 8():558. PubMed ID: 28824454
[No Abstract] [Full Text] [Related]
20. Longer term effects of ouabain on the contractility of rat isolated cardiomyocytes and on the expression of Ca and Na regulating proteins.
Müller-Ehmsen J; Nickel J; Zobel C; Hirsch I; Bölck B; Brixius K; Schwinger RH
Basic Res Cardiol; 2003 Mar; 98(2):90-6. PubMed ID: 12607130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
